25.07.2018 • NewsPerstorpinvestmentcapacity expansion

Perstorp proceeds with UK Caprolactone Upgrad

Perstorp proceeds with UK Caprolactone Upgrad © Perstorp
Perstorp proceeds with UK Caprolactone Upgrad © Perstorp

Swedish chemical producer Perstorp continues to make progress on upgrading its caprolactone plant in Warrington, UK. The project due to be completed in the second half of 2019 entails installation of a new peracetic still as well as new reactors to permit a higher production volume and facilitate expansion and debottlenecking.

A first upgrade was undertaken in 2011 with the addition of a second train. Work on the latest phase will begin sometime this year and is not expected to interfere with ongoing production. For the most part, this will entail demolition of much of the original plant built in the 1990s and reconstruction on the same site.

At the heart of the upgrade will be the installation of a new peracetic still as well as new reactors to permit a higher production volume and facilitate expansion and debottlenecking of caprolactone, which the company uses to make its Capa-branded high molecular weight linear polyester.

Further improvement of plant safety is also a goal of the work in progress, the company said earlier, explaining that the introduction of state-of-the-art technology and information systems will mean that fewer manual interventions will be needed in future.

Stephen Lewis, vice president of the caprolactones business unit, said the Swedish company continues to see strong confidence and demand among its customers, in particular for its range of derivatives marketed under the names Capa Thermoplastics and Capa Polyols.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.